Dexamethasone and monophosphoryl lipid a induce a distinctive profile on monocyte-derived dendritic cells through transcriptional modulation of genes associated with essential processes of the immune response
Artículo
Open/ Download
Publication date
2017Metadata
Show full item record
Cómo citar
García González, Paulina
Cómo citar
Dexamethasone and monophosphoryl lipid a induce a distinctive profile on monocyte-derived dendritic cells through transcriptional modulation of genes associated with essential processes of the immune response
Author
- García González, Paulina;
- Schinnerling, Katina;
- Sepúlveda Gutierrez, Alejandro;
- Maggi, Jaxaira;
- Mehdi, Ahmed M.;
- Nel, Hendrik J.;
- Pesce Reyes, Bárbara;
- Larrondo Lillo, Milton;
- Aravena, Octavio;
- Molina Sampayo, María Carmen;
- Catalán Martina, Diego;
- Thomas, Ranjeny;
- Verdugo Salgado, Ricardo;
- Aguillón Gutiérrez, Juan Carlos;
Abstract
There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target for immunotherapy. However, the molecular bases that drive the differentiation of monocyte-derived DCs (moDCs) toward a tolerogenic state are still poorly understood. Here, we studied the transcriptional profile of moDCs from healthy subjects, modulated with dexamethasone (Dex) and activated with monophosphoryl lipid A (MPLA), referred to as Dex-modulated and MPLA-activated DCs (DM-DCs), as an approach to identify molecular regulators and pathways associated with the induction of tolerogenic properties in tolDCs. We found that DM-DCs exhibit a distinctive transcriptional profile compared to untreated (DCs) and MPLA-matured DCs. Differentially expressed genes downregulated by DM included MMP12, CD1c, IL-1B, and FCER1A involved in DC maturation/inflammation and genes upregulated by DM included JAG1, MERTK, IL-10, and IDO1 involved in tolerance. Genes related to chemotactic responses, cell-to-cell signaling and interaction, fatty acid oxidation, metal homeostasis, and free radical scavenging were strongly enriched, predicting the activation of alternative metabolic processes than those driven by counterpart DCs. Furthermore, we identified a set of genes that were regulated exclusively by the combined action of Dex and MPLA, which are mainly involved in the control of zinc homeostasis and reactive oxygen species production. These data further support the important role of metabolic processes on the control of the DC-driven regulatory immune response. Thus, Dex and MPLA treatments modify gene expression in moDCs by inducing a particular transcriptional profile characterized by the activation of tolerance-associated genes and suppression of the expression of inflammatory genes, conferring the potential to exert regulatory functions and immune response modulation.
Patrocinador
Fondecyt-Chile
1140553
Millenium Institute on Immunology and Immunotherapy
P09/016-F
Indexation
Artículo de publicación ISI
Quote Item
Front. Immunol. 8:1350
Collections
The following license files are associated with this item: